ERD

Dissemination reporting

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

Award of PhD degrees

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

Lorlatinib Treatment Elicits Multiple On- and Off-Target Mechanisms of Resistance in ALK-Driven Cancer

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

An anaplastic cardiac large cell lymphoma: A case report and analysis of cardiac involvement in newly diagnosed non-Hodg...

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

Phosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved oncogenic ...

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

Existence of reprogrammed lymphoma stem cells in a murine ALCL-like model

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

EMMPRIN (CD147) is induced by C/EBPβ and is differentially expressed in ALK+ and ALK− anaplastic large-cell lymphoma

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib ...

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

Proteomic Phosphosite Analysis Identified Crucial NPM-ALK-Mediated NIPA Serine and Threonine Residues

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

Mutational profile and EBV strains of extranodal NK/T-cell lymphoma, nasal type in Latin America

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

NPM1c alters FLT3-D835Y localization and signaling in acute myeloid leukemia

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

Current Immunotherapeutic Approaches in T Cell Non-Hodgkin Lymphomas

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

We shall overcome (drug resistance) some day

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

Crizotinib-induced immunogenic cell death in non-small cell lung cancer

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

Oncogenic JAK2 V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

NPM-ALK-reactive T-cell responses in children and adolescents with NPM-ALK positive anaplastic large cell lymphoma

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

High activation of STAT5A drives peripheral T-cell lymphoma and leukemia

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphom...

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

Treatment Options for Paediatric Anaplastic Large Cell Lymphoma (ALCL): Current Standard and beyond

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

The Role of Oncogenic Tyrosine Kinase NPM-ALK in Genomic Instability

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

Targeting Autophagy in ALK-Associated Cancers

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer

Project: ALKATRAS

Updated at: 28-04-2024

Show more information

Project acronym ALKATRAS

Resources

Selected filters:

Dissemination reporting

Award of PhD degrees

Lorlatinib Treatment Elicits Multiple On- and Off-Target Mechanisms of Resistance in ALK-Driven Cancer

An anaplastic cardiac large cell lymphoma: A case report and analysis of cardiac involvement in newly diagnosed non-Hodg...

Phosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved oncogenic ...

Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells

Existence of reprogrammed lymphoma stem cells in a murine ALCL-like model

Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis

EMMPRIN (CD147) is induced by C/EBPβ and is differentially expressed in ALK+ and ALK− anaplastic large-cell lymphoma

A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib ...

Proteomic Phosphosite Analysis Identified Crucial NPM-ALK-Mediated NIPA Serine and Threonine Residues

Mutational profile and EBV strains of extranodal NK/T-cell lymphoma, nasal type in Latin America

NPM1c alters FLT3-D835Y localization and signaling in acute myeloid leukemia

Current Immunotherapeutic Approaches in T Cell Non-Hodgkin Lymphomas

Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases

We shall overcome (drug resistance) some day

Crizotinib-induced immunogenic cell death in non-small cell lung cancer

Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma

Oncogenic JAK2 V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms

NPM-ALK-reactive T-cell responses in children and adolescents with NPM-ALK positive anaplastic large cell lymphoma

Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells

High activation of STAT5A drives peripheral T-cell lymphoma and leukemia

Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma

The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphom...

Treatment Options for Paediatric Anaplastic Large Cell Lymphoma (ALCL): Current Standard and beyond

The Role of Oncogenic Tyrosine Kinase NPM-ALK in Genomic Instability

Targeting Autophagy in ALK-Associated Cancers

The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas

Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma

Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer